Indicators
Indicators
Value
Direction
MACD(12,26,9)
-14.292
Sell
RSI(14)
28.999
Sell
STOCH(KDJ)(9,3,3)
5.004
Oversold
ATR(14)
18.140
Low Volatility
CCI(14)
-122.950
Sell
Williams %R
97.007
Oversold
TRIX(12,20)
-0.539
Sell
StochRSI(14)
0.000
Oversold
Search
Intuitive Surgical Inc
ISRGAdd to Watchlist
332.030USD
-8.660-2.54%
Close 07-23 16:00（ET）Quotes delayed by 15 min
117.67BMarket Cap
39.70P/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-2.54%
5 Days
-17.47%
1 Month
-17.65%
6 Months
-36.63%
Year to Date
-41.37%
1 Year
-33.85%
Key Figures
338.200Open
340.550High
4.89MVolume
39.70P/E TTM
27.42P/E Dynamic
--Dividend TTM
1.38%Turnover Ratio
340.690Prev. Close
328.570Low
1.20BTurnover
50.66P/E Static
6.73P/B
0.00%Div Yield TTM
15.25%ROA
603.88052wk High
0.75Volume Ratio
2.32BNet Profit
354.40MShares
8.3634EPS TTM
1.65Beta
17.23%ROE
425.00052wk Low
3.52%Amplitude
67.78%Gross Margin
117.67BMarket Cap
-8.81Reward/Risk
1.73%Risk Rate
TradingKey Stock Score of Intuitive Surgical Inc
Currency: USD Updated: 2026-07-23Key Insights
Intuitive Surgical Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 27 out of 200 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 504.88.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Intuitive Surgical Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
50°C
Very Low
Very High
Negative
Intuitive Surgical Inc Highlights
StrengthsRisks
Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 41.28% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 10.06B.
Undervalued
The company’s latest PE is 39.70, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 316.11M shares, decreasing 0.85% quarter-over-quarter.
Held by Frank Sands
Star Investor Frank Sands holds 1.46M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.85.
Analyst Rating
Based on
34
analysts
Buy
Current Rating
504.885
Target Price
+44.23%
Upside Space
Intuitive Surgical Inc News
Intuitive Surgical (ISRG) Down 30% This Year; Can Tonight’s Q2 Earnings Reverse the Bearish Channel?
TradingKey - Intuitive Surgical reports Q2 2026 after the close today with consensus EPS of $2.50. The stock is down 30% this year despite beating estimates four quarters running. At $389 in a descending channel, tonight’s print is the catalyst the chart needs.
TradingKeyThu, Jul 16
ISRG: The "NVIDIA" of Robotic Surgery
Overall, we believe that as the leader in the rapidly growing surgical robot market, with its unique business model and ecosystem, it can continue to maintain its lead and constantly erode the market share of its competitors.
TradingKeyMay 19, 2025
Earnings Forecast
Analyst Rating
Based on
34
analysts
Buy
Current Rating
504.885
Target Price
+44.23%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
88
Total
4
Median
7
Average
Company name
Ratings
Analysts
Intuitive Surgical Inc
ISRG
34
Boston Scientific Corp
BSX
37
Edwards Lifesciences Corp
EW
33
Veeva Systems Inc
VEEV
30
Thermo Fisher Scientific Inc
TMO
30
Danaher Corp
DHR
26
1
2
3
...
18
Indicators
Moving Average
Indicators
Value
Direction
MA5
344.272
Sell
MA10
370.606
Sell
MA20
391.463
Sell
MA50
408.979
Sell
MA100
438.703
Sell
MA200
484.537
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Intuitive Surgical Inc Info
Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
Ticker SymbolISRG
CompanyIntuitive Surgical Inc
CEORosa (David J)
Websitehttps://www.intuitive.com/en-us/about-us/company
Shareholders
Related Instruments
-1.77%
+8.73%
+0.22%
-1.08%
+7.39%
+3.22%
+0.18%
+1.33%
-2.54%
+0.46%
+1.44%
+1.48%
-0.68%
-0.78%
-0.99%
-0.14%
+4.72%
+3.15%
+0.12%Popular Instruments
FAQs
What is the current price of Intuitive Surgical Inc (ISRG)?
The current price of Intuitive Surgical Inc (ISRG) is 332.03.
What is the symbol of Intuitive Surgical Inc?
The ticker symbol of Intuitive Surgical Inc is ISRG.
What is the 52-week high of Intuitive Surgical Inc?
The 52-week high of Intuitive Surgical Inc is 603.88.
What is the 52-week low of Intuitive Surgical Inc?
The 52-week low of Intuitive Surgical Inc is 425.00.
What is the market capitalization of Intuitive Surgical Inc?
The market capitalization of Intuitive Surgical Inc is 117.67B.
Is Intuitive Surgical Inc (ISRG) currently rated as Buy, Hold, or Sell?
According to analysts, Intuitive Surgical Inc (ISRG) has an overall rating of Buy, with a price target of 504.88.
What is the Earnings Per Share (EPS TTM) of Intuitive Surgical Inc (ISRG)?
The Earnings Per Share (EPS TTM) of Intuitive Surgical Inc (ISRG) is 8.00.